Virtus Family Office’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Virtus Family Office's PFE Position: Q1 2026 in Review
Virtus Family Office increased its Pfizer (PFE) stake by 0.43% in Q1 2026, buying an estimated $7.38K and bringing the position to 64,401 shares worth $1.81M. The position accounts for 1.54% of the portfolio, ranked #19.
Virtus Family Office first reported a position in PFE in Q3 2022 and has held it in 13 quarters since. The position peaked at $2.17M in Q4 2024. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Virtus Family Office held 64,401 shares of Pfizer worth $1.81M as of Q1 2026.
- Virtus Family Office bought 277 Pfizer shares in Q1 2026, an estimated $7.38K.
- Pfizer made up 1.54% of Virtus Family Office's portfolio in Q1 2026, its #19 holding.
- Virtus Family Office first reported a position in Pfizer in Q3 2022 and has held it in 13 quarters since.
- Virtus Family Office's Pfizer position peaked at $2.17M in Q4 2024.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Virtus Family Office's 13F filing for Q1 2026, filed 7 May 2026.